Abbvie Inc
Amgen Inc.
AstraZeneca
Biogen
Bristol Myers Squibb Company
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
Johnson & Johnson Services
Inc
Merck & Co. Inc
Novartis AG
Sanofi
UCB S.A
Published | Pages | Publisher | Report code |
---|---|---|---|
Jun 2024 | 200 | Diligence Insights | ASDR-666872 |
Abbvie Inc
Amgen Inc.
AstraZeneca
Biogen
Bristol Myers Squibb Company
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
Johnson & Johnson Services
Inc
Merck & Co. Inc
Novartis AG
Sanofi
UCB S.A